GlaxoSmithKline PLC (G1SK34)

B3
Currency in BRL
42.52
+0.56(+1.33%)
Delayed Data

G1SK34 Cash Flow Statement

Advanced Cash Flow Statement
Collapse All
Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
Cash from Operations
aa.aaaa.aaaa.aaaa.aaaa.aa8,4417,9527,4036,7686,554
Cash from Operations Growth
Net Income
Depreciation & Amortization, Total
Amortization of Deferred Charges, Total
Other Non-Cash Items, Total
Change in Net Operating Assets
aa.aaaa.aaaa.aaaa.aaaa.aa+5.25%-5.79%-6.9%-8.58%-3.16%
aa.aaaa.aaaa.aaaa.aaaa.aa5,7494,38514,9564,9282,575
aa.aaaa.aaaa.aaaa.aaaa.aa2,0502,1221,9432,0912,671
aa.aaaa.aaaa.aaaa.aaaa.aa--204203-
aa.aaaa.aaaa.aaaa.aaaa.aa-2751,121-8,342402-782
aa.aaaa.aaaa.aaaa.aaaa.aa917324-1,358-8562,090
Cash from Investing
aa.aaaa.aaaa.aaaa.aaaa.aa2,161-1,777-8,772-1,595-1,229
Cash from Investing Growth
Capital Expenditure
Sale of Property, Plant, and Equipment
Cash Acquisitions
Divestitures
Other Investing Activities
aa.aaaa.aaaa.aaaa.aaaa.aa+140.36%-182.23%-393.64%+81.82%+22.95%
aa.aaaa.aaaa.aaaa.aaaa.aa-989-950-1,143-1,314-1,399
aa.aaaa.aaaa.aaaa.aaaa.aa491321462865
aa.aaaa.aaaa.aaaa.aaaa.aa-120-114-3,187-1,468-824
aa.aaaa.aaaa.aaaa.aaaa.aa117-17-4349-18
aa.aaaa.aaaa.aaaa.aaaa.aa3,104-828-4,5451,110947
Cash from Financing
aa.aaaa.aaaa.aaaa.aaaa.aa-10,132-7,589823-5,641-4,726
Cash from Financing Growth
Total Debt Issued
Short Term Debt Issued, Total
Long-Term Debt Issued, Total
Total Debt Repaid
Short Term Debt Repaid, Total
Long-Term Debt Repaid, Total
Issuance of Common Stock
Repurchase of Common Stock
Issuance of Preferred Stock
Repurchase of Preferred Stock
Common & Preferred Stock Dividends Paid
Special Dividend Paid
Other Financing Activities
Foreign Exchange Rate Adjustments
Miscellaneous Cash Flow Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa-450.65%+25.1%+110.84%-785.42%+16.22%
aa.aaaa.aaaa.aaaa.aaaa.aa3,2983012,0462231,341
aa.aaaa.aaaa.aaaa.aaaa.aa-3011,021-266
aa.aaaa.aaaa.aaaa.aaaa.aa3,298-1,0252231,075
aa.aaaa.aaaa.aaaa.aaaa.aa-7,514-2,485-6,870-2,790-2,733
aa.aaaa.aaaa.aaaa.aaaa.aa-7,332-2,304-5,074-2,449-892
aa.aaaa.aaaa.aaaa.aaaa.aa-182-181-1,796-341-1,841
aa.aaaa.aaaa.aaaa.aaaa.aa2921251020
aa.aaaa.aaaa.aaaa.aaaa.aa-----
aa.aaaa.aaaa.aaaa.aaaa.aa-----
aa.aaaa.aaaa.aaaa.aaaa.aa-----
aa.aaaa.aaaa.aaaa.aaaa.aa-3,977-3,999-3,467-2,247-2,444
aa.aaaa.aaaa.aaaa.aaaa.aa-----
aa.aaaa.aaaa.aaaa.aaaa.aa-1,968-1,4279,089-837-910
aa.aaaa.aaaa.aaaa.aaaa.aa-39-29152-99-54
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Change in Cash
aa.aaaa.aaaa.aaaa.aaaa.aa431-1,443-394-567545
Beginning Cash Balance
Ending Cash Balance
Levered Free Cash Flow
Levered Free Cash Flow Growth
Free Cash Flow Yield
aa.aaaa.aaaa.aaaa.aaaa.aa5,8615,7174,1173,5033,325
aa.aaaa.aaaa.aaaa.aaaa.aa6,2924,2743,7232,9363,870
aa.aaaa.aaaa.aaaa.aaaa.aa5,562.754,8474,949.383,562.134,450.5
aa.aaaa.aaaa.aaaa.aaaa.aa+16.31%-12.87%+2.11%-28.03%+24.94%
aa.aaaa.aaaa.aaaa.aaaa.aa--3.57%3.00%2.19%
* In Millions of GBP (except for per share items)